Context: Cancers of the buccal mucosa (CaBM) predominate in India with late- stage diagnosis and poor survival. necessitating optimal management. Aim: Our study aimed at testing the efficacy of combination neoadjuvant chemotherapy (NACT) using cisplatin (CIS). bleomycin (BL) and methotrexate (MTX) for reducing tumour volume prior to surgery. https://www.markbroyard.com/